However, what we do know is that the osmotic diuretic effect of SGLT2 inhibitors may lead to hypovolemia, especially when used in combination with diuretics, and even dehydration due to excessive diuresis (29), which could lead to thrombotic events such as cerebral infarction. The gene discussed is SLC5A2; the disease is brain infarction.